Int'l Covid-19 vaccine poll shows higher mistrust of Russia, China shots

Int'l Covid-19 vaccine poll shows higher mistrust of Russia, China shots

PanARMENIAN.Net - People across the world are generally likely to say yes to getting a Covid-19 vaccine, but would be more distrustful of shots made in China or Russia than those developed in Germany or the United States, an international poll showed on Friday, January 15, according to Reuters.

Confidence among populations about vaccines will be a key factor in governments’ efforts to curb the rate of infections in the year-long SARS-CoV-2 coronavirus pandemic, which has infected more than 92 million people worldwide and killed at least 1.98 million.

The survey, conducted by the polling company YouGov, found Britons and Danes were the most willing to take the Covid-19 vaccine when it becomes available to them, while the French and Poles were more likely to be hesitant.

The poll was based on questions put to almost 19,000 people.

It also found that willingness to take the Covid-19 vaccine has been improving in many countries in recent weeks, just as shots developed by companies in the United States, Russia, China, Germany and Britain were starting to be delivered and administered in countries across Europe, North America and Asia.

In Britain, 73% of people said they would get vaccinated, while in Denmark the number was 70%.

In the United States, however, just less than half of those surveyed said they would be willing to have a Covid-19 vaccine, a figure that has remained broadly stable since July.

 Top stories
Azerbaijani authorities report that they have already resettled 3,000 people in the Nagorno-Karabakh town of Stepanakert.
On June 10, Azerbaijani President of Azerbaijan Ilham Aliyev will leave for Turkey on a working visit.
Azerbaijani President Ilham Aliyev arrived in Moscow on April 22 to hold talks with Russian counterpart Vladimir Putin.
Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive.
Partner news
---